577 filings
424B3
PRTG
Portage Biotech Inc
30 Apr 24
Prospectus supplement
6:23pm
6-K
PRTG
Portage Biotech Inc
30 Apr 24
Current report (foreign)
6:21pm
424B3
PRTG
Portage Biotech Inc
12 Apr 24
Prospectus supplement
5:22pm
6-K
PRTG
Portage Biotech Inc
12 Apr 24
Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives
5:21pm
424B3
PRTG
Portage Biotech Inc
8 Mar 24
Prospectus supplement
5:30pm
6-K
ekeyo0wrlnt koozm
8 Mar 24
Current report (foreign)
5:04pm
424B3
djl7cv7cjmauc
6 Mar 24
Prospectus supplement
9:36pm
6-K
yii18f
6 Mar 24
Current report (foreign)
9:11pm
6-K
zu229 94wqnk5f
28 Feb 24
Company focused on adenosine platform clinical development
6:42pm
424B3
dkdiweguyvj oa
28 Feb 24
Prospectus supplement
5:19pm
6-K
fl3e4e bghudju9fyd
28 Feb 24
Current report (foreign)
5:17pm
424B3
y3ilpo6ikn34 78pd2
18 Jan 24
Prospectus supplement
5:41pm
6-K
jzl7bugnl
18 Jan 24
Current report (foreign)
5:09pm
424B3
ibfeo4r
4 Jan 24
Prospectus supplement
5:49pm
6-K
my5iv s159c0
4 Jan 24
Current report (foreign)
8:10am
S-8
blnsa44mfd 0s4x0
1 Dec 23
Registration of securities for employees
4:05pm
424B3
kyjyqy26hc4hkol2axte
28 Nov 23
Prospectus supplement
4:03pm
6-K
gerbd77
28 Nov 23
PORT 2 and 6 Presented at the Society for Immunotherapy of Cancer’s (SITC) Annual Meeting
4:02pm
6-K
hdr qqkdyptb
28 Nov 23
Current report (foreign)
4:01pm
424B3
zpovbw
14 Nov 23
Prospectus supplement
6:00am